Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence J Egan

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2004
Drug interactions in gastroenterology: mechanisms, consequences, and how to avoidLaurence J Egan
Journal of Crohn'S & Colitis|September 9, 2017
Ten Years of the Journal of Crohn's and ColitisLaurence J Egan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
A nudge in the right direction: shaping the metabolic fate of thiopurines for therapeutic gainLaurence J Egan
Inflammatory Bowel Diseases|June 5, 2007
Allopurinol and 6MP: steering through the therapeutic obstacle courseLaurence J Egan
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Mechanisms of drug toxicity or intoleranceLaurence J Egan
Carcinogenesis|January 12, 2012
Inflammation, DNA methylation and colitis-associated cancerLori Hartnett, Laurence J Egan
Annals of the New York Academy of Sciences|October 24, 2006
NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approachLaurence J Egan, Murat Toruner
Gut|January 2, 2014
Taking a closer look at IBDLaurence J Egan, William Sandborn
Current Gastroenterology Reports|November 30, 2005
Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitisLaurence J Egan, William J Sandborn
Inflammatory Bowel Diseases|September 9, 2015
New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel DiseaseStephanie M Slevin, Laurence J Egan
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2004
Drug interactions in gastroenterology: mechanisms, consequences, and how to avoidLaurence J Egan
Journal of Crohn'S & Colitis|September 9, 2017
Ten Years of the Journal of Crohn's and ColitisLaurence J Egan
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
A nudge in the right direction: shaping the metabolic fate of thiopurines for therapeutic gainLaurence J Egan
Inflammatory Bowel Diseases|June 5, 2007
Allopurinol and 6MP: steering through the therapeutic obstacle courseLaurence J Egan
Digestive Diseases (Basel, Switzerland)|July 8, 2011
Mechanisms of drug toxicity or intoleranceLaurence J Egan
Carcinogenesis|January 12, 2012
Inflammation, DNA methylation and colitis-associated cancerLori Hartnett, Laurence J Egan
Annals of the New York Academy of Sciences|October 24, 2006
NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approachLaurence J Egan, Murat Toruner
Gut|January 2, 2014
Taking a closer look at IBDLaurence J Egan, William Sandborn
Current Gastroenterology Reports|November 30, 2005
Positioning novel biologic, probiotic, and apheresis therapies for Crohn's disease and ulcerative colitisLaurence J Egan, William J Sandborn
Inflammatory Bowel Diseases|September 9, 2015
New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel DiseaseStephanie M Slevin, Laurence J Egan
Pageof 6